MRAI - Marpai, Inc. Stock Price, Fair Value and News

2.07USD0.00 (0.00%)Delayed as of 30 Apr 2024, 02:07 pm ET

Market Summary

USD2.070.00

Delayedas of 30 Apr 2024, 02:07 pm

0.00%

MRAI Stock Price

View Fullscreen

MRAI RSI Chart

MRAI Valuation

Market Cap

21.3M

Price/Earnings (Trailing)

-0.74

Price/Sales (Trailing)

0.57

EV/EBITDA

-0.85

Price/Free Cashflow

-1.35

MRAI Price/Sales (Trailing)

MRAI Profitability

EBT Margin

-78.16%

Return on Equity

213.95%

Return on Assets

-90.76%

Free Cashflow Yield

-73.86%

MRAI Fundamentals

MRAI Revenue

Revenue (TTM)

37.2M

Rev. Growth (Yr)

14.14%

Rev. Growth (Qtr)

-0.26%

MRAI Earnings

Earnings (TTM)

-28.8M

Earnings Growth (Yr)

41.09%

Earnings Growth (Qtr)

31.09%

Breaking Down MRAI Revenue

52 Week Range

0.412.35

(Low)(High)

Last 7 days

-1.0%

Last 30 days

-15.2%

Last 90 days

50%

Trailing 12 Months

-20.8%

How does MRAI drawdown profile look like?

MRAI Financial Health

Current Ratio

0.82

MRAI Investor Care

Buy Backs (1Y)

51.89%

Diluted EPS (TTM)

-4.21

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	27.8M	32.3M	36.1M	37.2M
2022	16.8M	19.3M	21.8M	24.3M
2021	0	0	0	14.2M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Marpai, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 07, 2024	lamendola damien	bought	1,501,500	1.65	910,000	chief executive officer
Jan 17, 2024	dendy michael charles	acquired	-	-	50,000	-
Jan 17, 2024	calabrese jennifer rosario	acquired	-	-	50,000	-
Jan 17, 2024	pons robert m	acquired	-	-	50,000	-
Jan 16, 2024	lamendola damien	bought	1,012,110	0.9201	1,100,000	chief executive officer
Jan 16, 2024	eitan yaron	bought	193,221	0.9201	210,000	-
Jan 16, 2024	pons robert m	bought	11,133	0.9201	12,100	-
Jan 11, 2024	powers john paul	acquired	-	-	150,000	president
Dec 14, 2023	lamendola damien	bought	295,500	1.97	150,000	chief executive officer
Dec 14, 2023	pons robert m	bought	21,901	1.81	12,100	-

Which funds bought or sold MRAI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Mar 11, 2024	VANGUARD GROUP INC	reduced	-18.22	91,336	169,736	-%
Feb 14, 2024	SABBY MANAGEMENT, LLC	sold off	-100	-197,690,000	-	-%
Feb 14, 2024	Cubist Systematic Strategies, LLC	new	-	129,568	129,568	-%
Feb 14, 2024	STATE STREET CORP	new	-	35,887	35,887	-%
Feb 13, 2024	GEODE CAPITAL MANAGEMENT, LLC	added	28.48	51,742	74,488	-%
Feb 13, 2024	BlackRock Inc.	unchanged	-	90.00	144	-%
Feb 13, 2024	Tower Research Capital LLC (TRC)	reduced	-21.2	2,087	4,008	-%
Feb 12, 2024	JPMORGAN CHASE & CO	added	640	62.00	65.00	-%
Feb 09, 2024	HRT FINANCIAL LP	sold off	-100	-7,000	-	-%
Feb 09, 2024	UBS Group AG	new	-	203	203	-%

Are Funds Buying or Selling MRAI?

Are funds buying MRAI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MRAI

No. of Funds

Unveiling Marpai, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 11, 2024	lamendola damien	40.4%	4,146,597	SC 13D/A
Feb 13, 2024	altium capital management lp	0%	0	SC 13G/A
Jan 19, 2024	eitan yaron	7.7%	720,902	SC 13D/A
Jan 19, 2024	lamendola damien	34.3%	3,236,597	SC 13D/A
Dec 18, 2023	lamendola damien	28.5%	2,306,631	SC 13D/A
Nov 28, 2023	lamendola damien	27.6%	2,156,631	SC 13D/A
Nov 24, 2023	eitan yaron	5.9%	2,471,535	SC 13D/A
Apr 26, 2023	altium capital management lp	6.2%	1,805,327	SC 13G
Aug 29, 2022	lamendola damien	34.1%	7,046,384	SC 13D/A
Aug 23, 2022	lamendola damien	32.7%	6,754,129	SC 13D/A

Recent SEC filings of Marpai, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 17, 2024	DEFR14A	DEFR14A
Apr 17, 2024	8-K	Current Report
Mar 26, 2024	8-K	Current Report
Mar 26, 2024	10-K	Annual Report
Mar 18, 2024	PRE 14A	PRE 14A
Mar 14, 2024	DEF 14A	DEF 14A
Mar 13, 2024	8-K	Current Report
Mar 11, 2024	SC 13D/A	13D - Major Acquisition
Mar 08, 2024	8-K	Current Report
Mar 08, 2024	4	Insider Trading

Peers (Alternatives to Marpai, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	450.9B	371.6B	-1.15%	-0.62%	20.14	1.21	14.64%	11.24%
CI	104.2B	195.3B	-1.86%	40.72%	19.4	0.53	8.17%	-20.79%
CVS	84.9B	357.8B	-15.43%	-7.99%	10.16	0.24	10.95%	93.52%
HCA	82.4B	65.0B	-6.63%	8.38%	15.71	1.27	7.86%	-7.11%
CNC	39.5B	155.5B	-5.93%	7.11%	14.44	0.25	6.34%	84.42%
DVA	12.1B	12.1B	0.07%	52.88%	17.52	1	4.57%	23.40%
UHS	11.7B	14.3B	-7.31%	12.48%	16.33	0.82	6.59%	6.24%
MID-CAP
CHE	8.6B	2.3B	-11.65%	2.88%	30.26	3.74	5.96%	18.29%
ACHC	6.9B	2.9B	-5.81%	3.22%	-317.8	2.35	12.20%	-107.93%
AMN	2.3B	3.8B	-4.85%	-31.12%	10.69	0.59	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.84%	6.68%	34.56	1.51	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.86%	15.22%	24.45	1.44	11.31%	35.83%
BKD	1.3B	3.0B	4.54%	61.07%	-6.92	0.43	6.74%	20.73%
BEAT	54.0M	-	-5.96%	-9.29%	-3.69	-	-	-12.94%
AMS	20.6M	21.3M	10.17%	16.91%	38.6	0.96	8.00%	-62.25%

Marpai, Inc. News

Latest updates

Marpai, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2
Revenue	-0.3%	8,706,874	8,729,152	10,046,980	9,672,045	7,628,454	4,938,105	5,556,506	6,218,809	5,509,030	4,799,251	3,531,512
Costs and Expenses	-12.0%	13,862,103	15,757,435	17,317,668	18,194,827	16,568,314	10,752,561	12,220,438	11,757,416	11,645,353	9,535,008	7,502,559
S&GA Expenses	-40.1%	1,102,535	1,842,018	1,473,311	2,179,117	2,108,795	1,053,814	2,216,788	1,559,116	1,932,443	1,588,981	1,122,665
R&D Expenses	-92.2%	20,785	267,269	523,432	500,209	1,024,054	781,750	1,309,157	593,107	615,773	568,817	285,363
EBITDA Margin	16.2%	-0.64	-0.76	-0.81	-0.93	-0.95	-0.94	-1.00	-1.02	-0.97	-	-
Interest Expenses	10.9%	425,404	383,756	333,279	385,010	259,363	2,908	562	3,945	42,614	108,503	92,621
Income Taxes	-	-	-	-	-	-	-	-	-	-	-	-150,000
Earnings Before Taxes	27.1%	-5,317,189	-7,295,380	-7,556,620	-8,872,849	-9,055,216	-5,779,860	-6,664,782	-5,489,664	-5,728,668	-4,792,579	-4,021,974
EBT Margin	14.0%	-0.78	-0.91	-0.97	-1.09	-1.11	-1.08	-1.18	-1.20	-1.13	-	-
Net Income	31.1%	-5,027,051	-7,295,380	-7,556,620	-8,872,849	-8,534,084	-5,779,860	-6,664,782	-5,489,664	-5,728,668	-4,792,579	-3,871,974
Net Income Margin	13.5%	-0.77	-0.89	-0.95	-1.07	-1.09	-1.08	-1.18	-1.19	-1.12	-	-
Free Cashflow	93.5%	-449,206	-6,916,783	-2,452,828	-6,832,356	-20,192,674	-5,274,499	-6,706,131	-3,428,763	-5,475,500	-691,087	-4,132,450

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet											(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2020Q4
Assets	-11.0%	32.00	36.00	44.00	42.00	50.00	25.00	32.00	40.00	44.00	27.00	7.00
Current Assets	1.6%	17.00	17.00	24.00	20.00	27.00	10.00	16.00	23.00	27.00	10.00	2.00
Cash Equivalents	-62.0%	1.00	3.00	9.00	6.00	14.00	5.00	9.00	14.00	26.00	1.00	2.00
Net PPE	-7.8%	1.00	1.00	1.00	1.00	2.00	1.00	1.00	1.00	1.00	1.00	0.00
Goodwill	-50.0%	3.00	6.00	6.00	6.00	6.00	2.00	2.00	2.00	2.00	2.00	-
Liabilities	0.6%	45.00	45.00	46.00	44.00	44.00	11.00	13.00	15.00	14.00	23.00	10.00
Current Liabilities	1.9%	21.00	20.00	22.00	17.00	17.00	9.00	10.00	12.00	11.00	15.00	3.00
Shareholder's Equity	-Infinity%	-13.44	-	-	-	6.00	14.00	19.00	24.00	30.00	5.00	-
Retained Earnings	-7.0%	-76.75	-71.70	-64.42	-56.87	-47.99	-39.46	-33.68	-27.02	-21.53	-15.80	-5.54
Additional Paid-In Capital	1.3%	63.00	62.00	62.00	55.00	54.00	53.00	53.00	51.00	51.00	20.00	2.00
Shares Outstanding	1.9%	8.00	8.00	7.00	21.00	5.00	5.00	5.00	5.00	5.00	2.00	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)														(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3
Cashflow From Operations	93.2%	-449	-6,600	-2,160	-6,539	-19,900	-5,216	-6,794	-3,327	-5,268	-650	-4,115	-760	-	-
Share Based Compensation	-69.1%	262	847	367	623	673	689	1,078	666	269	256	476	230	-	-
Cashflow From Investing	11050.7%	1,000	9.00	15.00	3.00	33,303	-260	-125	-494	-462	-279	10,895	-509	-	-
Cashflow From Financing	-914800.7%	-1,335	146*	6,432	221*	-	-	-	-	22,664	2,050	178	376	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

MRAI Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)

12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Income Statement [Abstract]

Revenue

$ 37,155,050

$ 24,341,874

Costs and expenses

Cost of revenue (exclusive of depreciation and amortization shown separately below)

24,239,117

17,136,330

General and administrative

19,176,895

12,318,529

Sales and marketing

6,596,981

6,938,513

Information technology

5,834,255

6,372,795

Research and development

1,311,695

3,708,068

Depreciation and amortization

3,896,833

3,538,237

Impairment of goodwill

3,017,600

Facilities

2,472,192

1,012,827

Loss on disposal of assets

335,106

273,430

Gain on sale of business unit

(1,748,641)

Total costs and expenses

65,132,033

51,298,729

Operating loss

(27,976,983)

(26,956,855)

Other income (expenses)

Other income, net

488,869

234,472

Interest expense

(1,527,449)

(266,778)

Foreign exchange loss

(26,475)

(361)

Loss before provision for income taxes

(29,042,038)

(26,989,522)

Income tax benefit

(290,138)

(521,132)

Net loss

$ (28,751,900)

$ (26,468,390)

Net loss per share, basic (1)

^[1]

$ (4.14)

$ (5.23)

Net loss per share, fully diluted (1)

^[1]

$ (4.14)

$ (5.23)

Weighted average number of common shares, basic (1)

^[1]

6,951,669

5,059,959

Weighted average number of common shares, diluted (1)

^[1]

6,951,669

5,059,959

[1]	Reflects1-for-4 reverse stock split that became effective June 29, 2023. See Note 1 to the consolidated financial statements.

MRAI Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($)

Dec. 31, 2023

Dec. 31, 2022

Current assets:

Cash and cash equivalents

$ 1,146,801

$ 13,764,508

Restricted cash

12,344,583

9,352,608

Accounts receivable, net

1,125,159

1,437,786

Unbilled receivable

768,374

350,393

Prepaid expenses and other current assets

891,526

1,601,920

Total current assets

17,084,949

26,537,849

Property and equipment, net

610,860

1,506,082

Capitalized software, net

2,127,694

4,588,706

Operating lease right-of-use assets

2,372,839

3,841,810

Goodwill

3,017,600

5,837,060

Intangible assets, net

5,176,772

6,323,279

Security deposits

1,266,632

1,293,166

Other long-term asset

21,668

Total assets

31,679,014

49,949,620

Current liabilities:

Accounts payable

4,648,837

1,457,670

Accrued expenses

2,816,154

5,274,716

Accrued fiduciary obligations

11,572,713

9,024,463

Deferred revenue

660,826

288,499

Current portion of operating lease liabilities

512,416

1,311,295

Total current liabilities

20,842,530

17,359,844

Other long-term liabilities

19,401,398

20,203,700

Operating lease liabilities, net of current portion

3,683,822

4,771,871

Deferred tax liabilities

1,189,742

1,479,880

Total liabilities

45,117,492

43,815,295

COMMITMENTS AND CONTINGENCIES (Note 19)

STOCKHOLDERS' (DEFICT) EQUITY

Common stock, $0.0001 par value, 227,791,050 shares authorized; 7,960,938 issued and outstanding at December 31, 2023 and 5,319,758 issued and outstanding at December 31, 2022

^[1]

796

532

Additional paid-in capital

63,306,726

54,127,893

Accumulated deficit

(76,746,000)

(47,994,100)

Total stockholders' (deficit) equity

(13,438,478)

6,134,325

Total liabilities and stockholders' (deficit) equity

31,679,014

49,949,620

Nonrelated Party

Current assets:

Other receivables

8,506

30,634

Current liabilities:

Other short-term liability

631,584

Related Party

Current assets:

Other receivables

$ 800,000

Current liabilities:

Other short-term liability

$ 3,201

[1]	Reflects1-for-4 reverse stock split that became effective June 29, 2023. See Note 1 to the consolidated financial statements.

About Marpai, Inc.

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York.

CEO	Mr. Edmundo Gonzalez
WEBSITE	marpaihealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	303

Marpai, Inc. Frequently Asked Questions

What is the ticker symbol for Marpai, Inc.? What does MRAI stand for in stocks?

MRAI is the stock ticker symbol of Marpai, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Marpai, Inc. (MRAI)?

As of Mon Apr 29 2024, market cap of Marpai, Inc. is 21.32 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MRAI stock?

You can check MRAI's fair value in chart for subscribers.

What is the fair value of MRAI stock?

You can check MRAI's fair value in chart for subscribers. The fair value of Marpai, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Marpai, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MRAI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Marpai, Inc. a good stock to buy?

The fair value guage provides a quick view whether MRAI is over valued or under valued. Whether Marpai, Inc. is cheap or expensive depends on the assumptions which impact Marpai, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MRAI.

What is Marpai, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 29 2024, MRAI's PE ratio (Price to Earnings) is -0.74 and Price to Sales (PS) ratio is 0.57. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MRAI PE ratio will change depending on the future growth rate expectations of investors.